{"id":"W4236870775","doi":"10.2165/00128415-200309640-00002","title":"Novo Nordisk Canada Inc. has informed healthcare professionals that the concomitant use of repaglinide and gemfibrozil is now contraindicated,","year":2003,"lang":"en","type":"article","venue":"Reactions Weekly","topic":"Cardiovascular Syncope and Autonomic Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"","keywords":"Gemfibrozil; Repaglinide; Concomitant; Health professionals; Medicine; Health care; Pharmacology; Intensive care medicine; Political science; Internal medicine; Law; Metformin","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003307317,0.0001562085,0.0004098005,0.00007854906,0.0002446077,0.00002947773,0.00006423987,0.00009895632,0.00008133944],"category_scores_gemma":[0.0003662672,0.0001088275,0.0001456411,0.0001818395,0.0001859841,0.0001375104,0.00002817049,0.0002588016,0.000008554332],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001801802,"about_ca_system_score_gemma":0.003136219,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.1578763,"about_ca_topic_score_gemma":0.1859535,"domain_scores_codex":[0.9987096,0.00009996979,0.0004110834,0.0002215615,0.0003086159,0.0002491507],"domain_scores_gemma":[0.9985815,0.0004006452,0.0002056421,0.0005090845,0.0001444853,0.0001586062],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001019139,0.001100269,0.2203673,0.001836632,0.006744368,0.0002843404,0.00612814,0.00008177503,0.003944521,0.007367993,0.7001321,0.05099348],"study_design_scores_gemma":[0.001645754,0.00006948359,0.04874629,0.0001945864,0.0001865587,0.000292059,0.003882735,0.00004129633,0.001067175,0.00003787911,0.9436886,0.0001475921],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9422106,0.002149673,0.00008731725,0.04795296,0.000534259,0.001405138,0.000233204,0.00005305086,0.005373797],"genre_scores_gemma":[0.9933205,0.0006078249,0.0001880644,0.002911034,0.0000306878,0.00003797766,0.0000448132,0.00002088296,0.00283822],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2435565,"threshold_uncertainty_score":0.8477315,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03866814944724065,"score_gpt":0.2778605089024198,"score_spread":0.2391923594551791,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}